Company intelligence / Profile preview

Symphony Innovation

Los Altos, California, United States

Ownership: Private
Development stage: Other

Overview

Symphony Innovation appears to be the legal entity behind SymphonyAI, a private enterprise artificial intelligence software business rather than a biotechnology, pharmaceutical, or healthcare therapeutics company. Available business-registry and company-profile sources indicate the entity is an active U.S. LLC that was originally formed as Symphony Incubator and later renamed Symphony Innovation LLC. Public descriptions associate it with packaged AI software and analytics products for industrial and enterprise use, not with a drug-development pipeline. While some Symphony-branded businesses mention work with healthcare or life sciences customers, the requested entity itself does not appear to be a life science or biopharma operating company.

Industry: Drug Discovery Services

Beyond the preview

Go deeper on Symphony Innovation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Symphony Innovation.

Explore the full profile